Abstract
No AccessJournal of UrologyAdult Urology1 Jul 2013Re: MRI Assessment of Early Tumor Response in Metastatic Renal Cell Carcinoma Patients Treated with Sorafenib Cary SiegelM.D. Cary SiegelCary Siegel More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2013.04.016AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Re: MRI Assessment of Early Tumor Response in Metastatic Renal Cell Carcinoma Patients Treated with Sorafenib." The Journal of Urology, 190(1), pp. 62–63 © 2013 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 190Issue 1July 2013Page: 62-63Supplementary Materials Advertisement Copyright & Permissions© 2013 by American Urological Association Education and Research, Inc.MetricsAuthor Information Cary Siegel More articles by this author Expand All Advertisement PDF DownloadLoading ...
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
